LATE-BREAKING ABSTRACT: Effect of allogenic bone marrow transplant on cardiac function and pulmonary vascular pressure

E. Al Mutairy, N. Chaudhri, M. Al Jurf, A. Al Dalaan, S. Erwi, S. Saleemi, M. Khalid (Riyadh, Saudi Arabia)

Source: Annual Congress 2013 –New physiologic boundaries
Session: New physiologic boundaries
Session type: Poster Discussion
Number: 4978
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Al Mutairy, N. Chaudhri, M. Al Jurf, A. Al Dalaan, S. Erwi, S. Saleemi, M. Khalid (Riyadh, Saudi Arabia). LATE-BREAKING ABSTRACT: Effect of allogenic bone marrow transplant on cardiac function and pulmonary vascular pressure. Eur Respir J 2013; 42: Suppl. 57, 4978

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension after bone marrow transplantation in children
Source: Eur Respir J, 54 (5) 1900612; 10.1183/13993003.00612-2019
Year: 2019



Lung transplantation for pulmonary arterial hypertension
Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results
Year: 2015



Cardiac remodelling and hemodynamic changes in pulmonary hypertension after double lung transplantation
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017

Pulmonary function and respiratory complications in hematopoietic cell transplant
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016


Effects of transplantation on lung and exercise physiology
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=220
Year: 2003

LATE-BREAKING ABSTRACT: The effect of volume overload on pulmonary hypertension in hemodialysis patients
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015


Advanced pulmonary arterial hypertension: mechanical support and lung transplantation
Source: Eur Respir Rev, 26 (146) 170089; 10.1183/16000617.0089-2017
Year: 2017



Lung transplantation for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 247-255
Year: 2012


Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012



Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
Source: Eur Respir J 2005; 25: 490-493
Year: 2005



Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

Pulmonary distribution of oxygen partial pressure in lung transplant recipients: assessment by oxygen-sensitive 3He-MRI to indicate bronchiolitis obliterans (BO)
Source: Eur Respir J 2005; 26: Suppl. 49, 176s
Year: 2005

LATE-BREAKING ABSTRACT: Nitrogen multiple breath washout for diagnosis of biopsy-proven bronchiolitis obliterans in patients after allogeneic stem cell transplantation
Source: International Congress 2016 – Dyspnoea and respiratory muscle/mechanics anomalies in disease
Year: 2016

Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007



Monitoring of lung function and airways inflammation after bone marrow transplantation
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008


Pulmonary involvement in haematological disorders and bone marrow transplant recipients
Source: Eur Respir Monogr 2019; 86: 333-358
Year: 2019


Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung
Source: Eur Respir J 2003; 21: 192-194
Year: 2003